IN2014DN07920A - - Google Patents
Info
- Publication number
- IN2014DN07920A IN2014DN07920A IN7920DEN2014A IN2014DN07920A IN 2014DN07920 A IN2014DN07920 A IN 2014DN07920A IN 7920DEN2014 A IN7920DEN2014 A IN 7920DEN2014A IN 2014DN07920 A IN2014DN07920 A IN 2014DN07920A
- Authority
- IN
- India
- Prior art keywords
- cystathionine
- cbs
- synthase
- purification
- prepared therefrom
- Prior art date
Links
- 102100034976 Cystathionine beta-synthase Human genes 0.000 abstract 1
- 108010073644 Cystathionine beta-synthase Proteins 0.000 abstract 1
- 238000004587 chromatography analysis Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin or biotin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/01—Hydro-lyases (4.2.1)
- C12Y402/01022—Cystathionine beta-synthase (4.2.1.22)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615629P | 2012-03-26 | 2012-03-26 | |
| US13/830,494 US9243239B2 (en) | 2012-03-26 | 2013-03-14 | Purification of cystathionine beta-synthase |
| PCT/US2013/033716 WO2013148580A1 (en) | 2012-03-26 | 2013-03-25 | Purification of cystathionine beta-synthase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07920A true IN2014DN07920A (cg-RX-API-DMAC10.html) | 2015-05-01 |
Family
ID=49212017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7920DEN2014 IN2014DN07920A (cg-RX-API-DMAC10.html) | 2012-03-26 | 2013-03-25 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US9243239B2 (cg-RX-API-DMAC10.html) |
| EP (3) | EP3569706A1 (cg-RX-API-DMAC10.html) |
| JP (3) | JP6146934B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN104540940B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2013240003B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR112014023570B1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2867719C (cg-RX-API-DMAC10.html) |
| HK (1) | HK1246350B (cg-RX-API-DMAC10.html) |
| IL (2) | IL234635B (cg-RX-API-DMAC10.html) |
| IN (1) | IN2014DN07920A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013148580A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9034318B2 (en) | 2011-08-30 | 2015-05-19 | The Regents Of The University Of Colorado, A Body Corporate | Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria |
| US9243239B2 (en) * | 2012-03-26 | 2016-01-26 | The Regents Of The University Of Colorado, A Body Corporate | Purification of cystathionine beta-synthase |
| US9675678B2 (en) | 2013-01-29 | 2017-06-13 | The Regents Of The University Of Colorado, A Body Corporate | Compositions and methods for treatment of homocystinuria |
| DK3998067T3 (da) * | 2015-11-09 | 2024-10-28 | Univ Colorado Regents | Sammensætninger og fremgangsmåder til behandling af homocystinuri |
| CA3059592A1 (en) | 2017-04-17 | 2018-10-25 | The Regents Of The University Of Colorado, A Body Corporate | Optimization of enzyme replacement therapy for treatment of homocystinuria |
| US20220315965A1 (en) * | 2019-06-25 | 2022-10-06 | Zymergen Inc. | Engineered biosynthetic pathways for production of cystathionine by fermentation |
| MX2021015966A (es) * | 2019-06-26 | 2022-04-06 | Travere Therapeutics Switzerland Gmbh | Producto farmacológico para terapia enzimática para el tratamiento de la homocistinuria. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5576559A (en) | 1978-12-01 | 1980-06-09 | Chiyou Lsi Gijutsu Kenkyu Kumiai | Electron beam fine adjusting device |
| US5523225A (en) | 1993-09-13 | 1996-06-04 | Regents Of The University Of Colorado | DNA sequence encoding human cystathionine β-synthase |
| US5635375A (en) | 1995-01-09 | 1997-06-03 | Regents Of The University Of Colorado | Method of increasing the yield and heme saturation of cystathione β-synthase |
| WO2003106971A2 (en) | 2002-06-17 | 2003-12-24 | The Regents Of The University Of Colorado | HUMAN CYSTATHIONINE β-SYNTHASE VARIANTS AND METHODS OF PRODU CTION THEREOF |
| GB0216001D0 (en) * | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
| EP1396537A1 (en) | 2002-09-04 | 2004-03-10 | Avidis SA | Treatment of elevated plasma homocysteine |
| CN1552905A (zh) * | 2003-12-18 | 2004-12-08 | 中国农业科学院茶叶研究所 | 一类茶树胱硫醚-γ-合成酶特异表达序列标签及其生物芯片 |
| EP1878739A1 (en) | 2006-07-14 | 2008-01-16 | LEK Pharmaceuticals D.D. | One step IMAC (MCAC) purification of proteins |
| CA2788689C (en) | 2010-02-04 | 2019-07-02 | The Board Of Regents Of The University Of Texas System | Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof |
| US9243239B2 (en) | 2012-03-26 | 2016-01-26 | The Regents Of The University Of Colorado, A Body Corporate | Purification of cystathionine beta-synthase |
-
2013
- 2013-03-14 US US13/830,494 patent/US9243239B2/en active Active
- 2013-03-25 IN IN7920DEN2014 patent/IN2014DN07920A/en unknown
- 2013-03-25 WO PCT/US2013/033716 patent/WO2013148580A1/en not_active Ceased
- 2013-03-25 CA CA2867719A patent/CA2867719C/en active Active
- 2013-03-25 EP EP19179948.5A patent/EP3569706A1/en not_active Withdrawn
- 2013-03-25 EP EP17165825.5A patent/EP3263701B1/en active Active
- 2013-03-25 BR BR112014023570-8A patent/BR112014023570B1/pt active IP Right Grant
- 2013-03-25 CN CN201380027463.0A patent/CN104540940B/zh active Active
- 2013-03-25 AU AU2013240003A patent/AU2013240003B2/en active Active
- 2013-03-25 JP JP2015503433A patent/JP6146934B2/ja active Active
- 2013-03-25 EP EP13716577.5A patent/EP2831229B8/en active Active
-
2014
- 2014-09-14 IL IL234635A patent/IL234635B/en active IP Right Grant
-
2015
- 2015-12-16 US US14/970,814 patent/US10160962B2/en active Active
-
2017
- 2017-04-12 JP JP2017078808A patent/JP6839595B2/ja active Active
-
2018
- 2018-05-03 HK HK18105730.4A patent/HK1246350B/en unknown
- 2018-11-01 US US16/178,024 patent/US20190055537A1/en not_active Abandoned
- 2018-11-21 IL IL26316218A patent/IL263162B/en active IP Right Grant
-
2019
- 2019-10-11 JP JP2019187777A patent/JP6952361B2/ja active Active
-
2020
- 2020-01-10 US US16/739,169 patent/US10941392B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10160962B2 (en) | 2018-12-25 |
| US20190055537A1 (en) | 2019-02-21 |
| EP3263701A1 (en) | 2018-01-03 |
| AU2013240003A1 (en) | 2014-10-02 |
| US9243239B2 (en) | 2016-01-26 |
| JP6146934B2 (ja) | 2017-06-21 |
| EP3569706A1 (en) | 2019-11-20 |
| IL234635B (en) | 2018-12-31 |
| US10941392B2 (en) | 2021-03-09 |
| EP3263701B1 (en) | 2019-06-19 |
| AU2013240003B2 (en) | 2018-04-19 |
| JP6952361B2 (ja) | 2021-10-20 |
| CA2867719A1 (en) | 2013-10-03 |
| JP2015512639A (ja) | 2015-04-30 |
| WO2013148580A1 (en) | 2013-10-03 |
| BR112014023570B1 (pt) | 2022-03-15 |
| HK1246350B (en) | 2020-05-15 |
| CN104540940A (zh) | 2015-04-22 |
| US20160177287A1 (en) | 2016-06-23 |
| EP2831229A1 (en) | 2015-02-04 |
| EP2831229B8 (en) | 2018-10-17 |
| IL263162B (en) | 2019-11-28 |
| US20200131497A1 (en) | 2020-04-30 |
| BR112014023570A2 (pt) | 2021-06-01 |
| CA2867719C (en) | 2020-08-11 |
| EP2831229B1 (en) | 2017-10-18 |
| CN104540940B (zh) | 2018-03-06 |
| JP2017121255A (ja) | 2017-07-13 |
| IL263162A (en) | 2018-12-31 |
| US20130251700A1 (en) | 2013-09-26 |
| JP6839595B2 (ja) | 2021-03-10 |
| JP2020000259A (ja) | 2020-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN08481A (cg-RX-API-DMAC10.html) | ||
| AU2016204248A1 (en) | Boron-Containing Molecules | |
| IN2015DN00127A (cg-RX-API-DMAC10.html) | ||
| IL254879B (en) | History of dolastatin associated with unnatural amino acids and pharmaceutical preparations containing them | |
| MY168300A (en) | Pharmaceutical Composition for Inhalation | |
| GEP20196964B (en) | Pest control composition including novel iminopyridine derivative | |
| HK1210696A1 (en) | Irak inhibitors and uses thereof | |
| ZA201407726B (en) | Pharmaceutical compositions for combination therapy | |
| GEP20247677B (en) | Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds | |
| AU2013337247A8 (en) | XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions | |
| EP3022291A4 (en) | Compositions and methods for the biosynthesis of vanillin or vanillin beta-d-glucoside | |
| SG11201405578TA (en) | Pharmaceutical composition containing peptide | |
| MX2013013649A (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
| MY165075A (en) | Pharmaceutical composition comprising fimasartan and hydrochlorothiazide | |
| WO2014068586A3 (en) | Solid oral compositions of tolvaptan | |
| ZA201303024B (en) | Nasal compositions of vitamin b12 | |
| SI2814473T1 (sl) | Farmacevtske sestave za kombinirano terapijo | |
| BR112014023570A2 (pt) | Purificação de cistationina beta-sintase | |
| IN2015DN03132A (cg-RX-API-DMAC10.html) | ||
| MX2015003034A (es) | Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso. | |
| IN2014DN07103A (cg-RX-API-DMAC10.html) | ||
| MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
| IN2013MU03317A (cg-RX-API-DMAC10.html) | ||
| EP2930175A4 (en) | NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF | |
| WO2014122671A3 (en) | Solid oral compositions of saxagliptin |